Beatrice Schell

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Markus V. Heppt, Lucie Heinzerling, Katharina C. Kähler et al. · European Journal of Cancer · 2017 · 203 citations

Medicine, Immunology, Oncology +17

Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis

Markus V. Heppt, Thomas Eigentler, Katharina C. Kähler et al. · Cancer Immunology Immunotherapy · 2016 · 80 citations · Full text

Life Sciences, Immunology, Oncology +15

Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011

Olaf Schoffer, Stefanie Schülein, Gerlinde Arand et al. · BMC Cancer · 2016 · 34 citations · Full text

Medicine, Dermatology, Oncology +17

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis

Elias A. T. Koch, Anne Petzold, Anja Wessely et al. · Cancers · 2021 · 32 citations · Full text

Medicine, Immunology, Oncology +17

Clinical determinants of long-term survival in metastatic uveal melanoma

Elias A. T. Koch, Anne Petzold, Anja Wessely et al. · Cancer Immunology Immunotherapy · 2021 · 21 citations · Full text

Medicine, Dermatology, Oncology +17